Why is this important
The DS market in Uzbekistan is actively growing, but remains poorly regulated. The fine is a signal to manufacturers and sellers: they will have to answer for manipulative advertising.
What happened
- An advertisement for the Forsil dietary supplement was circulated on social media, promising that “pain will disappear without a trace”.
- According to the “Law on Advertising”, dietary supplements cannot be marketed as medications.
- The Committee’s commission classified this as a violation of Article 35 of the law.
- An order has been issued to eliminate the violations and pay the fine.
- The company is obligated to prevent such incidents in the future.
What they say
The committee reminded that this is not the first violation in the field of dietary supplement advertising. Previously, similar claims were filed against Stop Diabet, Effect Herbals, Biomalham, and others.
Context
In August, the Committee demanded the removal of the dietary supplement “Triortasol Orosol+Rukh” from sale due to its similarity to the registered ORSA drug. Monitoring of unscrupulous advertising is intensifying against the backdrop of the growth of the domestic additive market.
